In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.
New findings highlight the potential of this combination therapy as a new option for people with PTSD who have not responded to standard treatments.
Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.
Your daily dose of the clinical news you may have missed.
Approximately 70% of US adults surveyed hope their primary care clinician will ask about their mental health during an appointment, regardless of the presenting issue.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.
Your daily dose of the clinical news you may have missed.
Findings from a systematic review and meta-analysis showed 1 in 3 youth with chronic pain were diagnosed with anxiety and 1 in 8 were diagnosed with depression.